Bleichroeder LP
Top Portfolio Positions
71 positions ·
$601,168,760 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GLD |
Spdr Gold Trust
|
475,000 | $204,387,750 | 34.00% | |
| GPGI |
GPGI, Inc.
Industrials
|
3,969,676 | $67,881,459 | 11.29% | |
| RHLD |
Resolute Holdings Management, Inc.
Industrials
|
314,166 | $50,989,141 | 8.48% | |
| SPY |
Spdr S&P 500 ETF Trust
|
67,645 | $43,992,249 | 7.32% | |
| LIN |
Linde PLC
Basic Materials
|
68,474 | $33,946,670 | 5.65% | |
| NMTC |
NEUROONE MEDICAL TECHNOLOGIES Corp
Healthcare
|
4,000,000 | $18,648,000 | 3.10% | |
| MDXH |
MDxHealth SA
Healthcare
|
7,378,333 | $16,970,165 | 2.82% | |
| IDN |
Intellicheck, Inc.
Technology
|
2,073,583 | $14,494,345 | 2.41% | |
| DUOT |
Duos Technologies Group, Inc.
Technology
|
1,627,806 | $11,166,749 | 1.86% | |
| INVE |
Identiv, Inc.
Industrials
|
2,884,495 | $10,672,631 | 1.78% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CRIS
Shares Held
Position Value (USD)
12 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,091,280 | 3,802,329 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,124,305 | 1,135,662 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,885,198 | 1,135,662 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,402,735 | 1,035,662 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,174,890 | 1,035,662 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $2,174,890 | 1,035,662 | Shares | Sole | 2025-03-31 | |
| 2024-12-31 | $1,592,849 | 520,539 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $134,744 | 24,999 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $172,493 | 24,999 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $271,739 | 24,999 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $318,737 | 24,999 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $164,743 | 24,999 | Shares | Sole | 2023-11-09 | |
| No 13F history on record for this holder in this stock. | ||||||